Additional information
White Powder
41451-91-6
ACI-052303
(2S,4aR,4'R,5'S,6'S,7R,8S,9R,10R,12R,14R,15R,16S)-7-ethyl-5',8,9,14-tetrahydroxy-4'-methoxy-4',6',8,10,12,14,16-heptamethyl-15-3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyloxyhexadecahydrospiro5H,11H-1,3-dioxino5,4-coxacyclotetradecin-2,2'-pyrane-5,11-dione (erythromycin E)
(2S,4aR,4'R,5'S,6'S,7R,8S,9R,10R,12R,14R,15R,16S)-7-ethyl-5',8,9,14-tetrahydroxy-4'-methoxy-4',6',8,10,12,14,16-heptamethyl-15-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]hexadecahydrospiro[5H,11H-1,3-dioxino[5,4-c]oxacyclotetradecin-2,2'-pyrane]-5,11-dione (erythromycin E)
168.1-171.6°C
C37H65NO14
747.91
Ambient
2-8°C
1,16-Epoxy-erythromycin
Antibiotic





![LINAGLIPTIN DIMER (25 mg) (N¹,N²-Bis{(R)-1-[7-(but-2-yn-1-yl)-3-methyl-1-{(4-methylquinazolin-2-yl)methyl}-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}phthalamide)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)